TUMOR MARKER INDEX (TMI) BASED ON CYFRA21-1 AND CEA IDENTIFIES P-STAGE I NSCLC PATIENTS WITH HIGH RISK OF RECURRENCE AND POOR PROGNOSIS

被引：0
|
作者：
Muley, Thomas R. [1 ]
Hoffmann, Hans [1 ]
Dienemann, Hendrik [2 ]
Thomas, Michael [3 ]
Herth, Felix J. F. [4 ]
Meister, Michael [1 ]
机构：
[1] Univ Heidelberg, Translat Res Unit, Thoraxklin, D-6900 Heidelberg, Germany
[2] Univ Heidelberg, Dept Surg, Thoraxklin, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Dept Thorac Oncol, Thoraxklin, D-6900 Heidelberg, Germany
[4] Univ Heidelberg, Dept Pneumol & Resp Med, Thoraxklin, D-6900 Heidelberg, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Tumor marker index; Stage I; risk prediction; Prognosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1041 / S1042
页数：2
相关论文
共 21 条
  • [1] TUMOR MARKER INDEX (TMI) BASED ON CYFRA 21-1 AND CEA IDENTIFIES P-STAGE I NSCLC PATIENTS WITH HIGH RISK OF RECURRENCE. POTENTIAL CANDIDATES FOR ADJUVANT CHEMOTHERAPY?
    Muley, T.
    Stolp, C.
    Hoffmann, H.
    Dienemann, H.
    Thomas, M.
    Herth, F. J. F.
    Meister, M.
    TUMOR BIOLOGY, 2010, 31 : S87 - S87
  • [2] Tumor Marker Index (TMI) based on CYFRA 21-1 and CEA predicts recurrence-free survival in P-Stage I NSCLC
    Muley, Thomas R.
    Traschuetz, Christa
    Hoffmann, Hans
    Dienemann, Hendrik
    Thomas, Michael
    Herth, Felix J.
    Meister, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S920 - S921
  • [3] PROGNOSTIC IMPACT OF TUMOR MARKER INDEX (TMI) IN COMPLETELY RESECTED P-STAGE 1 NSCLC PATIENTS
    Muley, T.
    Fetz, H.
    Scholz, S.
    Dienemann, H.
    Ebert, W.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3571 - 3571
  • [4] Prognostic value of a tumor marker index (TMI) based on CYFRA 21-1 and CEA in NSCLC patients treated by surgery
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4802 - 4803
  • [5] Correlations of pathological stage and prognosis of NSCLC patients with changes in serum CEA and CYFRA21-1 and CT characteristics
    Zhao, Wei
    Liu, Yanling
    Kong, Fanlei
    Li, Yongcai
    PANMINERVA MEDICA, 2020, 62 (01) : 67 - 69
  • [6] Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC
    Muley, Thomas
    Fetz, Timea-Helene
    Dienemann, Hendrik
    Hoffmann, Hans
    Herth, Felix J. F.
    Meister, Michael
    Ebert, Werner
    LUNG CANCER, 2008, 60 (03) : 408 - 415
  • [7] CORRELATION OF TUMOR VOLUME AND TUMOR MARKER INDEX (TMI) WITH SURVIVAL IN COMPLETELY RESECTED STAGE I/II NSCLC PATIENTS
    Muley, T.
    Fetz, H.
    Dienemann, H.
    Ebert, W.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3571 - 3571
  • [8] CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients
    Muley, T
    Dienemann, H
    Ebert, W
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1953 - 1956
  • [9] High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC:Possible Poor Prognostic Factors
    Xuefeng Lin
    Xiaodong Wang
    Daqiang Sun
    Zhi Li
    Yue Bai
    Cancer Biology & Medicine, 2012, (04) : 270 - 273
  • [10] High Serum CEA and CYFRA21-1 Levels after a Two-Cycle Adjuvant Chemotherapy for NSCLC:Possible Poor Prognostic Factors
    Xue-feng Lin
    Xiao-dong Wang
    Da-qiang Sun
    Zhi Li
    Yue Bai
    Cancer Biology & Medicine, 2012, 9 (04) : 270 - 273
123